| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 9 Oct 2026 | 30 Sep 2026 |
| Inter alia, to consider and transact the following businesses: 1.To consider and approve the appointment of Internal Auditor To consider and, if thought fit, approve the appointment of M/s Mahesh Sharma & Associates, Chartered Accountants, as the Internal Auditor of the Company for a period of five (5) financial years commencing from Financial Year 2026-27 and ending with Financial Year 2030-31, on such terms and conditions, including professional fees, as may be determined by the Board, subject to the applicable provisions of the Companies Act, 2013 and rules made thereunder and other applicable laws. 2. To consider and approve the appointment of Mr. Chandrashekhar Singh as Director To consider and, if thought fit, approve the appointment of Mr. Chandrashekhar Singh as a Director of the Company, subject to the applicable provisions of the Companies Act, 2013, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable laws, and subject to receipt and verification of the requisite consent, declarations and other documents. 3. To consider and approve such other matters as may be necessary or incidental to the above agenda items Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations), We Wish To Inform You That The Board Of Directors Of Blueblood Ventures Limited (The Company), At Its Meeting Held Today, I.E., Friday, 09 October 2026, At The Registered Office Of The Company, Has Considered And Approved The Following Matters: 1. Appointment Of Internal Auditor M/S. Mahesh Sharma & Associates, Chartered Accountants (Firm Registration No. 014330N), As The Internal Auditor Of The Company For The Financial Years 2026-27 To 2030-31. 2. The Appointment Of Mr. Chandrashekhar Singh (DIN: 05131693) As An Additional Director In The Category Of Non-Executive Independent Director Of The Company With Effect From 09 October 2026.3.Opening Of Branch Office At Kolkata. 4. Approved the Debt Assignment Transaction. (As per BSE Announcement dated on: 09.10.2026) | ||
| Board Meeting | 7 Sep 2026 | 7 Sep 2026 |
| This is to inform that the Board of Directors at their meeting held on Monday 07th September, 2026 has decided that Annual General Meeting of the Company will be held on Wednesday, the 30th September, 2026 at 11:30 A.M. at M-55 M Block Market, Greater Kailash-2, Top Floor, New Delhi-110048 | ||
| Board Meeting | 27 May 2026 | 15 May 2026 |
| Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve Blueblood Ventures Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve To approve Audited Standalone Financials Results of the Company for the half and Financial year ended 31st March2026. Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Blueblood Ventures Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve To approve Audited Standalone Financials Results of the Company for the half and Financial year ended 31st March,2026. (As Per BSE Announcement Dated On : 15.05.2026) Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015. The Standalone Annual Audited Financial Results for the Financial Year 2025-2026 along with Auditors Report thereon had been approved by the Board of Directors of the Company in its meeting held on 27th day of May,2026 and the said meeting commenced at 01:00 P.M. and Concluded at 03:00 P.M (As Per BSE Announcement Dated on:27.05.2026) | ||
| Board Meeting | 14 Nov 2025 | 6 Nov 2025 |
| Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Blueblood Ventures Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter-alias to consider and approve the Un-Audited Standalone Financial Results for the Second Quarter and half year ended 30th September 2025 Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015. The Standalone Quarterly and Half Yearly Results ended 30th September,2025 unaudited Financial results for the Financial Year 2025-2026 along with auditor report thereon had been approved by the Board of Directors of the Company in its meeting held on 14th day of November,2025 and the said meeting commenced at 14:00 P.M. and Concluded at 16:30 P.M (As Per BSE Announcement Dated on: 14/11/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
